NASDAQ · INDP
Indaptus Therapeutics, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for INDP: Nov 11, 2026
Indaptus Therapeutics, Inc. Common Stock is estimated to report earnings on 11/11/2026. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. The reported EPS for the same quarter last year was $-2.98.
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
RTTNews · BNK Invest · The Motley Fool · Quiver Quantitative- RTTNews · Oct 2, 2:50 PM EDTBiotech Stocks Move Higher – NIVF +25%, ICU +23%, ATRA +11%, INDP +9%(RTTNews) – Several biotech and healthcare stocks moved sharply higher, driven by company-specific developments including financing activity, regulatory updates and strategic initiatives.
- RTTNews · Sep 15, 2:43 PM EDTBiotech Stocks Gain Ground: PDS Biotech, Clene, Indaptus Lead Movers(RTTNews) – Several biotech stocks were in focus Tuesday, including PDS Biotech following a potential $22.55 million PIPE financing; Avaí Bio after completing testing of its GMP Master Cell Bank; Clene following a $4 million registered direct offering; NurExone after entering an
- RTTNews · Sep 10, 2:49 PM EDT5 Biotech Stocks In Spotlight: Tenon Medical, AEON Biopharma, Silexion, Orchestra BioMed & Indaptus(RTTNews) – Several biotech stocks were in focus Thursday, including Tenon Medical following the full repayment of its senior convertible promissory notes; AEON Biopharma after positive forced degradation study results for ABP-450; Silexion Therapeutics ahead of several September
- RTTNews · Jun 17, 11:15 PM EDTTop Biotech Gainers: QURE Rallies On AMT-130 Update, LNAI On Track, FTH Eyes Q4 Data, ELTX On Watch(RTTNews) – Today's top gainers included uniQure, which rallied after the FDA softened its stance on the company's investigational gene therapy; Elicio Therapeutics, following encouraging treatment responses from its cancer vaccine in pancreatic cancer trial; Lunai, after its CEO
- RTTNews · Jun 5, 9:14 AM EDTPre-Market Movers: BGMS, CMND, INDP Chart The Course(RTTNews) – Pre-market trading offers an early glimpse of biotech stocks likely to attract investor attention this Friday.
- BNK Invest · Jun 4, 12:56 PM EDTThursday Sector Leaders: Advertising, Biotechnology StocksIn trading on Thursday, advertising shares were relative leaders, up on the day by about 3.8%. Leading the group were shares of Advantage Solutions, up about 7.8% and shares of Thryv Holdings up about 7.6% on the day. Also showing relative strength are biotechnology shares, up
- RTTNews · May 26, 3:50 AM EDTTop Biotech Gainers: AKTX Rallies; GOVX Up On Ebola Concerns; SLGL Awaits Catalysts; CMMB On Watch(RTTNews) – Biotech stocks witnessed strong momentum on Friday, with Akari Therapeutics leading the pack, driven by encouraging preclinical pancreatic cancer data for AKTX-101. MetaVia, GeoVax, Polyrizon, and Sol-Gel were also some of the companies that captured Wall Street's at
- RTTNews · Dec 29, 7:51 AM ESTIndaptus Therapeutics Enters $6 Million Securities Deal, Appoints David Lazar Co-CEO And Chairman(RTTNews) – Indaptus Therapeutics, Inc. (INDP) on Monday said it has entered into a $6 million securities purchase agreement with investor David E. Lazar for the purchase of non-voting convertible preferred stock, alongside changes to its leadership and board structure.
- The Motley Fool · Aug 13, 8:12 AM EDTIndaptus Posts Narrower Loss in Q2GAAP EPS loss of $9.09 was narrower than the expected $9.24 per share for Q2 2025, a minor outperformance.
- Quiver Quantitative · Jul 1, 8:21 AM EDTIndaptus Therapeutics Raises $5.7 Million Through Convertible Promissory Notes and WarrantsIndaptus Therapeutics raised $5.7 million through the sale of convertible promissory notes and warrants for R&D purposes.
- RTTNews · Jun 25, 7:51 AM EDTIndaptus Therapeutics Sets 1-for-28 Reverse Stock Split(RTTNews) – Indaptus Therapeutics, Inc. (INDP) Wednesday said that its Board has approved a one-for-twenty eight reverse stock split effective June 26, 2025.
- Quiver Quantitative · Jun 25, 7:12 AM EDTIndaptus Therapeutics, Inc. Announces One-for-Twenty-Eight Reverse Stock Split to Enhance Nasdaq Compliance and Attract InvestorsIndaptus Therapeutics announces a one-for-twenty-eight reverse stock split effective June 27, 2025, to comply with Nasdaq requirements.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for Indaptus Therapeutics, Inc. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.